Global Cellular Immunotherapy Market Size & Outlook

The cellular immunotherapy industry worldwide is expected to reach a projected revenue of US$ 37,970.6 million by 2030. A compound annual growth rate of 22.4% is expected of the worldwide cellular immunotherapy industry from 2023 to 2030.

Revenue, 2022 (US$M)
$7,533.0
Forecast, 2030 (US$M)
$37,970.6
CAGR, 2023 - 2030
22.4%
Report Coverage
Worldwide

Global cellular immunotherapy market highlights

  • The global cellular immunotherapy market generated a revenue of USD 7,533.0 million in 2022 and is expected to reach USD 37,970.6 million by 2030.
  • The market is expected to grow at a CAGR (2023 - 2030) of 22.4% by 2030.
  • In terms of segment, car t cell therapy accounted for a revenue of USD 5,414.4 million in 2022.
  • CAR T Cell Therapy is the most lucrative therapy type segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2022.
  • Country-wise, U.S. is expected to register the highest CAGR from 2023 to 2030.

Global data book summary

Market revenue in 2022USD 7,533.0 million
Market revenue in 2030USD 37,970.6 million
Growth rate22.4% (CAGR from 2022 to 2030)
Largest segmentCar t cell therapy
Fastest growing segmentCAR T Cell Therapy
Historical data covered2018 - 2021
Base year for estimation2022
Forecast period covered2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCAR T Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy, TIL Therapy

Other key industry trends

  • In terms of revenue, the North America accounted for 40.8% of the global cellular immunotherapy market in 2022.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, U.S. is the fastest growing regional market and is projected to reach USD 11,403.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Cellular Immunotherapy Market Companies

Name Profile # Employees HQ Website

Global cellular immunotherapy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cellular immunotherapy market will help companies and investors design strategic landscapes.


car t cell therapy was the largest segment with a revenue share of 71.88% in 2022. Horizon Databook has segmented the Global cellular immunotherapy market based on car t cell therapy, dendritic cell therapy, nk cell therapy, til therapy covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Cellular Immunotherapy Therapy Type Outlook (Revenue, USD Million, 2018-2030)
    • CAR T Cell Therapy
    • Dendritic Cell Therapy
    • NK Cell Therapy
    • TIL Therapy
    • Others
  • Global Cellular Immunotherapy Indication Outlook (Revenue, USD Million, 2018-2030)
    • B-cell Malignancies
    • Prostate Cancer
    • Liver Cancer
    • Renal Cell Carcinoma
    • Others
  • Global Cellular Immunotherapy End Use Outlook (Revenue, USD Million, 2018-2030)
    • Others
    • Hospitals
    • Cancer Institutes

Reasons to subscribe to Global cellular immunotherapy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global cellular immunotherapy market databook

  • Our clientele includes a mix of cellular immunotherapy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global cellular immunotherapy market , including forecasts for subscribers. This global databook contains high-level insights into Global cellular immunotherapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global cellular immunotherapy market statistics, by region, 2018-2030 (US$M)

Top 10 countries: Cellular immunotherapy market size, 2022 (USD Million)

Top 10 countries: Cellular immunotherapy market size, 2022 (USD Million)

Global cellular immunotherapy market, by region, 2022 (US$M)

Global cellular immunotherapy market statistics, by region, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more